Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE Î4 allele

British Journal of Nutrition

Volumn 110, Issue 10, 2013, Pages 1751-1759

  Chouinard Watkins, R ^a,b   Rioux Perreault, C ^a   Fortier, M ^a   Tremblay Mercier, J ^a   Zhang, Y ^c   Lawrence, P ^c   Vohl, M C ^d   Perron, P ^b   Lorrain, D ^a,b   Brenna, J T ^c   Cunnane, S C ^a,b,d   Plourde, M ^a,b,d  

^a UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c Department of Obstetrics Gynecology   (United States)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Oxidation; ApoE 4; DHA; Metabolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARBON 13; CARBON DIOXIDE; DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; APOLIPOPROTEIN E4; CARBON; FAT INTAKE;

ADULT; AGED; ALLELE; APOE EPSILON4 GENE; ARTICLE; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BREATH ANALYSIS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GENE; GENE INTERACTION; GENETIC LINKAGE; GENOTYPE; HALF LIFE TIME; HETEROZYGOTE; HUMAN; ISOTOPE LABELING; MALE; METABOLIC DISORDER; ALZHEIMER DISEASE; ANIMAL; BLOOD; CLINICAL TRIAL; COGNITIVE DEFECT; DIET; FAT INTAKE; FISH; GENETICS; LIPID PEROXIDATION; METABOLISM; OXIDATION REDUCTION REACTION; STATISTICAL MODEL;

AGED; ALLELES; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E4; CARBON DIOXIDE; CARBON ISOTOPES; COGNITION; COGNITION DISORDERS; DIET; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; FEMALE; FISHES; GENOTYPE; HALF-LIFE; HUMANS; LINEAR MODELS; LIPID PEROXIDATION; MALE; OXIDATION-REDUCTION;

EID: 84887247737     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513001268     Document Type: Article

References (58)

1. Balk EM, Lichtenstein AH, Chung M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19-30. (Pubitemid 44468073)
2. Burillo E, Martin-Fuentes P, Mateo-Gallego R, et al. (2012) Omega-3 fatty acids and HDL. How do they work in the prevention of cardiovascular disease? Curr Vasc Pharmacol 10, 432-441.
3. Morris MC, Evans DA, Bienias JL, et al. (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60, 940-946. (Pubitemid 36858352)
4. Cunnane SC, Plourde M, Pifferi F, et al. (2009) Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 48, 239-256.
5. Fotuhi M, Mohassel P & Yaffe K (2009) Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 5, 140-152.
6. Beydoun MA, Kaufman JS, Satia JA, et al. (2007) Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 85, 1103-1111. (Pubitemid 46557928)
7. Heude B, Ducimetiere P & Berr C (2003) Cognitive decline and fatty acid composition of erythrocyte membranes-The EVA Study. Am J Clin Nutr 77, 803-808.
8. Schaeffer EL, Forlenza OV & Gattaz WF (2009) Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology (Berl) 202, 37-51.
9. Samieri C, Feart C, Proust-Lima C, et al. (2011) v-3 Fatty acids and cognitive decline: modulation by Apo-Eepsilon4 allele and depression. Neurobiol Aging 32, 2317.e13-2317.e22.
10. Corder EH, Saunders AM, Strittmatter WJ, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
11. Huang TL, Zandi PP, Tucker KL, et al. (2005) Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 65, 1409-1414. (Pubitemid 41552771)
12. Whalley LJ, Deary IJ, Starr JM, et al. (2008) n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 87, 449-454. (Pubitemid 351226084)
13. Horrocks LA & Yeo YK (1999) Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 40, 211-225. (Pubitemid 29435720)
14. Calon F, Lim GP, Yang F, et al. (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633-645. (Pubitemid 39179724)
15. Bouwens M, van de Rest O, Dellschaft N, et al. (2009) Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90, 415-424.
16. Plourde M & Cunnane SC (2007) Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619-634.
17. Castellano C, Chouinard-Watkins R, Brenna T, et al. (2011) Does aging change docosahexaenoic acid homeostasis? Oléagineux Corps Gras Lipides (OCL) 18, 175-180.
18. Cunnane SC, Chouinard-Watkins R, Castellano CA, et al. (2013) Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids 88, 61-70.
19. Plourde M, Vohl MC, Vandal M, et al. (2009) Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162 V polymorphism in men. Br J Nutr 102, 1121-1124.
20. Le PM, Fraser C, Gardner G, et al. (2007) Biosynthetic production of universally (13)C-labelled polyunsaturated fatty acids as reference materials for natural health product research. Anal Bioanal Chem 389, 241-249. (Pubitemid 47325228)
21. Brenna JT (1997) Use of stable isotopes to study fatty acid and lipoprotein metabolism in man. Prostaglandins Leukot Essent Fatty Acids 57, 467-472. (Pubitemid 27504745)
22. Brossard N, Croset M, Pachiaudi C, et al. (1996) Retroconversion and metabolism of [13C]22 : 6n-3 in humans and rats after intake of a single dose of [13C]22 : 6n-3-triacylglycerols. Am J Clin Nutr 64, 577-586. (Pubitemid 26334237)
23. Lemaitre-Delaunay D, Pachiaudi C, Laville M, et al. (1999) Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [13C]DHA in phosphatidylcholine. J Lipid Res 40, 1867-1874. (Pubitemid 29477257)
24. Plourde M, Chouinard-Watkins R, Vandal M, et al. (2011) Plasma incorporation, apparent retroconversion and betaoxidation of 13C-docosahexaenoic acid in the elderly. Nutr Metab (Lond) 8, 5.
25. Nasreddine ZS, Phillips NA, Bedirian V, et al. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695-699. (Pubitemid 41623495)
26. Freemantle E, Vandal M, Tremblay Mercier J, et al. (2009) Metabolic response to a ketogenic breakfast in the healthy elderly. J Nutr Health Aging 13, 293-298.
27. McCloy U, Ryan MA, Pencharz PB, et al. (2004) A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women. J Lipid Res 45, 474-485. (Pubitemid 38337994)
28. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
29. Goodman KJ & Brenna JT (1992) High sensitivity tracer detection using high-precision gas chromatography-combustion isotope ratio mass spectrometry and highly enriched [U-13C]-labeled precursors. Anal Chem 64, 1088-1095.
30. Choquette S, Chuin A, Lalancette DA, et al. (2009) Predicting energy expenditure in elders with the metabolic cost of activities. Med Sci Sports Exerc 41, 1915-1920.
31. Emi M, Wu LL, Robertson MA, et al. (1988) Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3, 373-379.
32. Hixson JE & Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548. (Pubitemid 20107994)
33. Cochran GWSWG (1980) Statistical Methods, 7th ed., pp. 507. Iowa State University, IA: Iowa State University Press.
34. Garenc C, Aubert S, Laroche J, et al. (2004) Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians. J Hum Genet 49, 691-700.
35. Bullido MJ, Artiga MJ, Recuero M, et al. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18, 69-71. (Pubitemid 28027883)
36. Littell RC, Henry PR & Ammerman CB (1998) Statistical analysis of repeated measures data using SAS procedures. J Anim Sci 76, 1216-1231. (Pubitemid 128437870)
37. Hooijmans CR & Kiliaan AJ (2008) Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 585, 176-196.
38. Mahley RW & Ji ZS (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40, 1-16. (Pubitemid 29022581)
39. Bahri R, Esteban E, Moral P, et al. (2008) Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease. Lipids Health Dis 7, 46.
40. Gregg RE, Zech LA, Schaefer EJ, et al. (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78, 815-821. (Pubitemid 16024820)
41. Carvalho-Wells AL, Jackson KG, Gill R, et al. (2010) Interactions between age and apoE genotype on fasting and postprandial triglycerides levels. Atherosclerosis 212, 481-487.
42. Kobayashi J, Saito Y, Taira K, et al. (2001) Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan. Atherosclerosis 154, 539-546. (Pubitemid 32232150)
43. Reznik Y, Morello R, Pousse P, et al. (2002) The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus. Metabolism 51, 1088-1092.
44. Litman BJ, Niu SL, Polozova A, et al. (2001) The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J Mol Neurosci 16, 237-242, discussion 79-84. (Pubitemid 32664785)
45. Serhan CN, Clish CB, Brannon J, et al. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192, 1197-1204.
46. Liang X, Zhu D & Schulz H (1999) Delta3,5,7,Delta2,4, 6-trienoyl-CoA isomerase, a novel enzyme that functions in the beta-oxidation of polyunsaturated fatty acids with conjugated double bonds. J Biol Chem 274, 13830-13835.
47. Lizard G, Rouaud O, Demarquoy J, et al. (2012) Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type. J Alzheimers Dis 29, 241-254.
48. Bakewell L, Burdge GC & Calder PC (2006) Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr 96, 93-99. (Pubitemid 44160901)
49. Burdge G (2004) Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7, 137-144. (Pubitemid 40340675)
50. Decsi T & Kennedy K (2011) Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr 94, Suppl. 6, 1914S-1919S.
51. Burdge GC & Calder PC (2005) Conversion of alphalinolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 45, 581-597. (Pubitemid 41511883)
52. Burdge GC & Wootton SA (2003) Conversion of alphalinolenic acid to palmitic, palmitoleic, stearic and oleic acids in men and women. Prostaglandins Leukot Essent Fatty Acids 69, 283-290. (Pubitemid 37463810)
53. Burdge GC & Wootton SA (2002) Conversion of alphalinolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88, 411-420. (Pubitemid 35251957)
54. Burdge GC, Jones AE & Wootton SA (2002) Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 88, 355-363. (Pubitemid 35251952)
55. Cauley JA, Gutai JP, Kuller LH, et al. (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129, 1120-1131. (Pubitemid 19148455)
56. Garry PJ, Baumgartner RN, Brodie SG, et al. (1999) Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene. Clin Chem 45, 1214-1223. (Pubitemid 29424260)
57. Wehr H, Parnowski T, Puzynski S, et al. (2000) Apolipoprotein E genotype and lipid and lipoprotein levels in dementia. Dement Geriatr Cogn Disord 11, 70-73. (Pubitemid 30114087)
58. Giltay EJ, van Reedt Dortland AK, Nissinen A, et al. (2009) Serum cholesterol, apolipoprotein E genotype and depressive symptoms in elderly European men: the FINE study. J Affect Disord 115, 471-477.